'Molecular testing' presentation slideshows

Molecular testing - PowerPoint PPT Presentation

Thank you for viewing this presentation.

Thank you for viewing this presentation.

Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS for your personal use only, as submitted by the author. 2011 by the author. Guidance for implementation of TB care in the EU: the ESTC.

★ ★ ★ ★ ★

901 views • 75 slides
Fouad Al Dayel, MD, FRCPA, FRCPath Professor and Chairman

Fouad Al Dayel, MD, FRCPA, FRCPath Professor and Chairman

25 th IAP-Arab Division Conference 07-09 November 2013, Amman, Jordan. MOLECULAR PREDICTIVE. MARKERS OF LUNG CARCINOMA:. KFSH&RC EXPERIENCE. Fouad Al Dayel, MD, FRCPA, FRCPath Professor and Chairman Department of Pathology and Laboratory Medicine

★ ★ ★ ★ ★

876 views • 47 slides
Contaminated Food – How to Evaluate Risk Liability Claims Subcommittee Meeting

Contaminated Food – How to Evaluate Risk Liability Claims Subcommittee Meeting

Contaminated Food – How to Evaluate Risk Liability Claims Subcommittee Meeting Washington DC September 17, 2009. Real Events Happening Daily to Real People. 76 million cases of foodborne illness annually 325,000 hospitalizations 5,000 deaths

★ ★ ★ ★ ★

449 views • 38 slides
MICR 454L

MICR 454L

MICR 454L. Emerging and Re-Emerging Infectious Diseases Lecture 11: SARS, Hantavirus (Reading: Emerging Viruses) Dr. Nancy McQueen & Dr. Edith Porter. Brief history Morphology Genome Replication cycle Diseases Pathogenesis Diagnosis Treatment Prevention Threat. Overview. SARS

★ ★ ★ ★ ★

893 views • 37 slides
research-driven data standards

research-driven data standards

research-driven data standards. CIMI 11 th April 2013. patient records. clinician’s notes for self or colleagues, for communication or justification notifications and summary reports against standard data sets

★ ★ ★ ★ ★

457 views • 36 slides
Positive Deviance: A Culture Change Management Approach to Reducing Health Care Acquired Infections

Positive Deviance: A Culture Change Management Approach to Reducing Health Care Acquired Infections

Positive Deviance: A Culture Change Management Approach to Reducing Health Care Acquired Infections . Michael Gardam Ontario Agency for Health Protection and Promotion University Health Network. Consider….

★ ★ ★ ★ ★

598 views • 31 slides
Horizon Scanning in Microbiology Diagnostics

Horizon Scanning in Microbiology Diagnostics

Horizon Scanning in Microbiology Diagnostics. Dr Jaisi Sinha Consultant Microbiologist and Virologist NPHS Microbiology, Cardiff. Outline of this Presentation. What are the traditional and newer diagnostic methods in microbiology?

★ ★ ★ ★ ★

832 views • 28 slides
Chapter 16

Chapter 16

Chapter 16. Quality Assurance and Quality Control in the Molecular Laboratory. Objectives. Describe proper specimen accession for molecular testing. Describe the optimal conditions for holding and storage of specimens and nucleic acid.

★ ★ ★ ★ ★

1.09k views • 28 slides
Smoking-related lung disease in 3D: not your standard lecture

Smoking-related lung disease in 3D: not your standard lecture

Smoking-related lung disease in 3D: not your standard lecture. Dani S. Zander , MD Professor and Chair, Dept. of Pathology Penn State College of Medicine/Penn State M.S. Hershey Medical Center, Hershey, PA. Smoking-Related Lung Diseases. Cause

★ ★ ★ ★ ★

537 views • 28 slides
Robert A. Myers Ph.D. Maryland DHMH Laboratories

Robert A. Myers Ph.D. Maryland DHMH Laboratories

Utilizing a Non-Commercial Real-Time PCR to Detect HIV-1 RNA in HIV Antibody Negative Diagnostic Sera Submitted to The Maryland Public Health Laboratory. Robert A. Myers Ph.D. Maryland DHMH Laboratories. Presentation Overview.

★ ★ ★ ★ ★

491 views • 28 slides
Approach to leucocytosis

Approach to leucocytosis

Approach to leucocytosis. Jackie Thomson. LYMPHOID. MYELOID. ACUTE / IMMATURE. MATURE/ CHRONIC. LYMPHOID. IMMATURE. MATURE. MYELOID. B-ALL T-ALL. LYMPHOID. IMMATURE. MATURE. MYELOID. B-ALL T-ALL. LYMPHOID. IMMATURE. MATURE. AML MDS. MYELOID. B-ALL T-ALL. LYMPHOID. CLL

★ ★ ★ ★ ★

451 views • 26 slides
Overview of Newborn Screening Molecular Assays

Overview of Newborn Screening Molecular Assays

Overview of Newborn Screening Molecular Assays. Susan M Tanksley, PhD June 28, 2011. Outline. Introduction to molecular testing for genetic diseases Brief history of molecular testing in NBS When & why to use a molecular test Availability of NBS molecular tests in different states

★ ★ ★ ★ ★

419 views • 22 slides
Molecular & Genomic Pathology in the Management of Cancer: Teaching...Who, When, What and How

Molecular & Genomic Pathology in the Management of Cancer: Teaching...Who, When, What and How

Molecular & Genomic Pathology in the Management of Cancer: Teaching...Who, When, What and How. Antonia R. Sepulveda MD., PhD Columbia University, NY, NY. Notice of Faculty Disclosure.

★ ★ ★ ★ ★

434 views • 18 slides
Molecular Testing and Clinical Diagnosis

Molecular Testing and Clinical Diagnosis

Molecular Testing and Clinical Diagnosis. Direct Nucleic Acid Testing. Non-amplified Probe Assays. Three main steps for direct nucleic acid testing 1. Sample preparation 2. Probe hybridization In solution On a solid surface 3. Detection. DNA Probe – An Example.

★ ★ ★ ★ ★

482 views • 17 slides
China IVD Market and Forecast to 2020

China IVD Market and Forecast to 2020

iGATE RESEARCH report titled “China IVD Market and Forecast to 2020” is a 86 page report with 34 Figures and 1 Table. This report studies in details the China IVD Market - Application Segment Wise, China IVD Market - Company Sales, Development Environment and Regulatory Status in China IVD market and Driving Factors and Challenges for China IVD Market. The China In Vitro Diagnostics (IVD) Market has been analyzed from 4 View Points: 1) Market and Forecast (2007 - 2020) 2) Segment Wise Market & Forecast (2007 - 2020) 3) Development Environment and Regulatory Status in China IVD market 4) Company Wise IVD Sales & Forecast (2010 - 2020) China IVD Market - 8 Application Segments Covered in the Report are: 1. Clinical Chemistry Market 2. Immunoassay Market 3. Hematology Market 4. Coagulation Market 5. Microbiology Market 6. Molecular Testing Market 7. Self Monitoring of Blood Glucose (SMBG) Market 8. Point of Care Testing (POCT) Market The Companies covered in the report are as follows: • Roche Diagnostic • Sysmex Corporation • Mindray Medical International Limited • Shanghai Kehua Bio-Engineering Co. Ltd. • Others Profiles of Private Clinical Labs and Diagnostic Services Companies in China • Zhejiang Di’an Diagnostics Technology Co., Ltd • ADICON Clinical Laboratories • Guangzhou Kingmed Diagnostics Center Co. Ltd. • Kindstar Global (Privately held) • BGI-Shenzhen (Privately held) • OriGene Technologies (Privately held) Click here to view the complete report: http://www.igateresearch.com/ProductDetail.php?pd_name=China IVD Market and Forecast to 2020 Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: 91-858-684-0791, 91-706-527-9335 (INDIA) Web: www.igateresearch.com

★ ★ ★ ★ ★

473 views • 13 slides
China In Vitro Diagnostics Market

China In Vitro Diagnostics Market

For more Info: https://www.renub.com/china-in-vitro-diagnostics-market-is-expected-to-grow-with-19-cagr-by-2022-32-nd.php The report China IVD Market, by Diagnostics [Clinical Chemistry, Immunoassay, Hematology, Coagulation, Microbiology, Molecular Testing, Self Monitoring of Blood Glucose (SMBG), Point of Care Testing (POCT)], Companies (Roche Diagnostics, Sysmex Corporation, Mindray Medical International Limited, Shanghai Kehua Bio-Engineering Co. Ltd., Abbott Laboratories & Others)” provides a complete analysis of China In–Vitro Diagnostics (IVD) Market. The market for China In-Vitro Diagnostics (IVD) is likely to exceed US$ 12 Billion by the end of year 2024. Request a free sample copy of the report: https://www.renub.com/contactus.php In Vitro Diagnostics (IVDs) - Devices and Reagents In Vitro Diagnostics (IVDs) are medical devices and accessories that are used to perform tests on the specimens taken from the human body such as blood, urine and tissue in order to treat, mitigate, monitor drug therapies, cure, or prevent illness or its abnormality. In vitro diagnostic (IVD) products are those reagents, instruments, and systems intended for use in the collection, preparation, and examination of specimens to diagnose disease or other conditions, including a decision of the state of health.

★ ★ ★ ★ ★

258 views • 12 slides
China In Vitro Diagnostics Market Forecast

China In Vitro Diagnostics Market Forecast

Access full Research: https://www.renub.com/china-in-vitro-diagnostics-ivd-market-forecast-companies-analysis-registration-rules-1089-p.php China IVD Market is projected to exceed US$ 12 Billion by the end of year 2024. China IVD Market is growing significantly and is expected to continue its ongoing trend during the forecast period as well, owing to rapidly increasing middle class population who is now willing to pay more for better healthcare services and aging population who are more vulnerable to contagious diseases. Also, Chinese aging population is experiencing an outburst of chronic diseases which includes cancer, diabetes and cardiovascular disease. All of these diseases can be diagnosed and monitored using IVD products. In addition; some other factors which can be attributed to China IVD market include growing prevalence of chronic lifestyle and infectious diseases, public health awareness, transformation of medical models, increasing demand of tests from the rural areas and support from the Chinese government to provide better healthcare infrastructure throughout the nation. Request a free sample copy of the report: https://www.renub.com/contactus.php Renub Research report titled “China In–Vitro Diagnostics (IVD) Market, By Diagnostics [Clinical Chemistry, Immunoassay, Hematology, Coagulation, Microbiology, Molecular Testing, Self Monitoring of Blood Glucose (SMBG), Point of Care Testing (POCT)], Companies (Roche Diagnostics, Sysmex Corporation, Mindray Medical International Limited, Shanghai Kehua Bio-Engineering Co. Ltd., Abbott Laboratories & Others)” provides a complete analysis of China In–Vitro Diagnostics (IVD) Market.

★ ★ ★ ★ ★

204 views • 12 slides
Molecular Assessment Program - MAP

Molecular Assessment Program - MAP

Molecular Assessment Program - MAP. Christopher N. Greene, PhD. Newborn Screening and Molecular Biology Branch, Division of Laboratory Sciences NCEH, CDC Tuesday, 28th June 2011. National Center for Environmental Health . U.S. Centers for Disease Control and Prevention.

★ ★ ★ ★ ★

214 views • 9 slides
Molecular Assessment Program - MAP

Molecular Assessment Program - MAP

Molecular Assessment Program - MAP. Christopher N. Greene, PhD. Newborn Screening and Molecular Biology Branch, Division of Laboratory Sciences NCEH, CDC Tuesday, 28th June 2011. National Center for Environmental Health . U.S. Centers for Disease Control and Prevention.

★ ★ ★ ★ ★

177 views • 9 slides
Mutation Testing: Why, When, Which and How?

Mutation Testing: Why, When, Which and How?

Mutation Testing: Why, When, Which and How?. Why?. Prognostic BRAF? Predictive Adjuvant Ulceration? Gene signature? Advanced disease BRAF RAS? CKIT?. When. Advanced disease Drive therapeutic decision Clonal evolution Delays and/or failed biopsy Primary resection Never needed

★ ★ ★ ★ ★

225 views • 8 slides

View Molecular testing PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Molecular testing PowerPoint presentations. You can view or download Molecular testing presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.